Abstract. The use of purified and overexpressed alcohol dehydrogenases to synthesize enantiopure fluorinated alcohols is shown. Performing the bioreductions with ADH-A from Rhodococcus ruber overexpressed in E. coli, no external cofactor was necessary to obtain the enantiopure (R)-derivatives.
3 described. 15 The synthesis of the corresponding racemic fluorohydrins was performed by simple treatment of the ketones with NaBH 4 in MeOH at 0ºC.
Scheme 1. Synthesis of α-fluoroacetophenone derivatives 3a-l
Due to our previous expertise in ADH-catalyzed reductions, 13, 16 we selected a series of purified and overexpressed biocatalysts (see the Experimental Section), to achieve the transformations using ketones 3a-l as substrates, together with fluorinated α-bromoacetophenones 2b and 2i, and also 2,2-difluoro-(4) and 2,2,2-trifluoroacetophenone (5) to compare the activity and selectivity with the monofluorinated compound 3a. Buffer Tris.HCl 50 mM pH 7.5 was selected as appropriate medium, except for brominated compounds 2b and 2i where Tris.H 2 SO 4 was employed to avoid undesired S N 2 reactions. 13 Furthermore, 1 mM of the corresponding nicotinamide cofactor was also added and 2-propanol or glucose with glucose dehydrogenase (GDH) to recycle it. After enzymatic screening, overexpressed
ADH-A from Rhodococcus ruber in E. coli (E. coli/ADH-A), 17 and commercially available ADH from
Lactobacillus brevis (LBADH) 18 were chosen as the best biocatalysts in terms of activity and selectivity.
The employment of these enzymes is highly desirable since they can work under the 'coupled-substrate' approach using 2-propanol to recycle the cofactor, diminishing processes costs and allowing higher substrate concentrations due to better ketone solubility in the aqueous buffer. Furthermore, due to the opposite stereopreference they show, it was possible to get access to both alcohol enantiomers.
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Therefore, substrates 2b, 2i, 3a-l, 4 and 5 (30 mM) were subjected under these biocatalytic conditions obtaining excellent results with both enzymes (Table 1) . Change in Cahn-Ingold-Prelog (CIP) priority.
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Gratefully, in every case the substrate was completely transformed into the enantiopure (R)-or (S)-alcohol when using ADH-A or LBADH, independently it bore electron withdrawing or electron donating groups at meta-or para-positions. Also di-or trifluorinated ketones 4 and 5 afforded perfect conversions and ee with both biocatalysts.
One additional advantage of working with overexpressed ADH preparations is the possibility to avoid the use of external cofactor when performing the bioreductions. 19 Therefore, some of these ketones were tested at higher substrate concentration with E. coli/ADH-A without the addition of external NADH (Table 2) . It was interesting to observe that in some cases the enantiopurity of the final alcohols slightly decreased. This could be probably due to the action of other NADP-dependent ADHs from the host organism that in the absence of additional NADH could compete with ADH-A diminishing the overall selectivity. Moreover, it was demonstrated that even at high concentrations such as 200 mM, conversions remained quantitative. In a next step, we decided to increase the substrate concentration keeping constant the quantity of LBADH in the presence of 1 mM of the nicotinamide cofactor and just increasing the amount of 2-PrOH, although due to the fact that α-halogenated ketones can be quasi-irreversibly reduced, 20 it was not necessary a huge excess of the hydrogen donor. A selection of the results obtained is shown in Figure 1 . (R)-6b is a precursor of cholesterol absorption inhibitors (CAI) such as AZD4121 or ezetimibe (Scheme 2), a class of compounds that have attracted attention for the treatment of hypercholesterolemia, related to several diseases as atherosclerosis.
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synthesized via asymmetric reduction with (R)-2-methyloxazaborolidine in the presence of boranedimethyl sulfide complex in THF at 0ºC. 22 With regards to biocatalyzed synthesis, Zhu and co-workers obtained the enantiopure (S)-alcohol using an isolated ADH from Candida magnolia with glucose and GDH to recycle the nicotinamide cofactor. Overall, with the systematic study shown here it was demonstrated that ADH-catalyzed hydrogen transfer reduction of α-fluoro ketones is a very convenient method to synthesize both alcohol antipodes in an enantiopure form at high substrate concentrations with excellent conversions. Thus, when performing the bioreduction in the presence of overexpressed enzymes it was also possible to avoid the use of external nicotinamide cofactor. Due to the nature of these activated ketones, it was not necessary the employment of a huge excess of the hydrogen donor.
Experimental Section
General. Acetophenones 1e, 1i, 1j, 1k, and 1l, α-bromoacetophenones 2b, 2c, 2d, 2f, 2g, and 2h, difluorinated ketone 4 and trifluorinated derivative 5 were obtained from commercial sources. All other reagents and solvents were of the highest quality available. LBADH from Lactobacillus brevis and GDH were obtained from commercial sources. The following overexpressed enzymes in E. coli have been 8 kindly provided by Prof. Wolfgang Kroutil from the University of Graz (Austria): ADH-A from
TeSADH from Thermoanaerobacter ethanolicus (E. coli/TeSADH).
Chemical reactions were monitored by analytical TLC, performed on silica gel 60 F254 plates and visualized by UV irradiation. Flash chromatography was performed using silica gel 60 (230-400 mesh).
Melting points were taken on samples in open capillary tubes and are uncorrected. IR spectra were recorded on an infrared Fourier transform spectrophotometer on NaCl pellets. 1 H-, 13 at 50˚C. After that time, the solvent was evaporated under reduced pressure. Then, a water solution of saturated NaHCO 3 (30 mL) was added and the solution was extracted with dichloromethane (3 x 30 mL). The organic layers were combined and dried over Na 2 SO 4 . The solvent was evaporated and the residue was subjected to column chromatography (silica gel) using hexanes/CH 2 Cl 2 (from 9:1 to 4:1) as eluent. These compounds exhibited physical and spectral data in agreement with those reported. 24 2e
(4.30 g, 88% yield), 2i (2.12 g, 66% yield), 2j (2.88 g, 82% yield), 2k (2.45 g, 71% yield), and 2l (2.60 g, 71% yield).
Synthesis of α-fluoroacetophenone derivatives 3.
A mixture of KF (4.8 mmol, 1.5 equiv), ZnF 2 (4.8 mmol, 1.5 equiv) in 7 mL of acetonitrile was stirred and heated at 100˚C in a sealed heavy-walled Pyrex tube for 1 h. Then, a solution of the substrate (3.2 mmol, 1.0 equiv) in acetonitrile (7 mL) was added into the reaction mixture. Then it was heated for 24 h at 100˚C. After that time, the solvent was evaporated under reduced pressure. Then, water (20 mL) was added and the solution was extracted with dichloromethane (3 x 20 mL). The organic layers were combined and dried over Na 2 SO 4 . The solvent was evaporated and the residue was subjected to column chromatography (silica gel) using hexanes/EtOAc (from 95:5 to 90:10) as eluent. These compounds exhibited physical and spectral data in agreement with those reported. 14,25 3b (230 mg, 47% yield), 3c (255 mg, 47% yield), 3d (625 mg, 90% yield), 3e (326 mg, 39% yield), 3f (274 mg, 56% yield), 3g (380 mg, 71% yield), 3h (210 mg, 36% yield), 3i (265 mg, 53% yield), 3j (367 mg, 66% yield), 3k (368 mg, 68% yield), and 3l (214 mg, 36% yield). General procedure for the synthesis of the racemic alcohols 6-9. To a solution of the corresponding ketone (4.0 mmol) in methanol (5 mL) at 0˚C, sodium borohydride (1.2 mmol) was added. When the reduction was completed (according to the TLC), a few drops of 1 M HCl were added.
2-Fluoro-4'-iodoacetophenone (3e
The solvent was evaporated under reduced pressure. Then, water (10 mL) was added and the solution was extracted with dichloromethane (3 x 10 mL). The organic layers were combined and dried over Na 2 SO 4 . The solvent was evaporated and the residue was subjected to column chromatography (silica gel) using mixtures of hexanes/ethyl acetate (from 9:1 to 4:1) as eluents. These compounds exhibited physical and spectral data in agreement with those reported. 23, 26 Isolated yields: 71-95%. [α] D 20 = +51.9 (c 1.34, CHCl 3 ), ee >99% (S). 
2-Bromo-1-(3-fluorophenyl)ethanol (6i

2-Fluoro-1-(4-iodophenyl)ethanol (7e
2-Fluoro-1-(4-methylphenyl)ethanol (7f
2-Fluoro-1-(3-fluorophenyl)ethanol (7i
2-Fluoro-1-(3-methoxyphenyl)ethanol (7k).
Light yellow oil; IR (NaCl) : 3056, 2950, 2838, 1603, 1587, 1489, 1467, 1456, 1436, 1320, 1267, 1158, 1043, 1010, 881, 786, 737 General procedure for an enzymatic reduction using LBADH from Lactobacillus brevis. In a 1.5 mL Eppendorf vial, LBADH (3 U) was added in Tris.HCl buffer 50 mM pH 7.5 (570 µL, 1 mM NADP + , 1 mM MgCl 2 ) and mixed with 2-propanol (30 μL, 5% v v -1 ) and the corresponding ketone (30 or 50 mM). The reaction was shaken at 30ºC and 250 rpm for 24 h and stopped by extraction with ethyl acetate (2 x 0.5 mL). The organic layer was separated by centrifugation (2 min, 13000 rpm) and dried over Na 2 SO 4 . Conversions and ee of the corresponding alcohols were determined by GC (see Tables 1 13 and S1). For α-brominated ketones, in order to avoid undesired S N 2 reactions with Tris.HCl buffer, 13 Tris.H 2 SO 4 buffer 50 mM pH 7.5 (570 µL, 1 mM NADP + , 1 mM MgBr 2 ) was used.
General procedure for an enzymatic reduction using E. coli/ADH-A from Rhodococcus ruber. In a 1.5 mL Eppendorf vial, E. coli/ADH-A (20 mg) was added in Tris-HCl buffer 50 mM pH 7.5 (570 µL, 1 mM NADH) and mixed with 2-propanol (30 μL, 5% v v -1 ) and the corresponding ketone (30 or 50 mM). The reactions were shaken at 30ºC and 250 rpm for 24 h and stopped by extraction with ethyl acetate (2 x 0.5 mL). The organic layer was separated by centrifugation (2 min, 13000 rpm) and dried over Na 2 SO 4 . Conversions and ee of the corresponding alcohols were determined by GC (see Tables 1 and S1). For α-brominated ketones, in order to avoid undesired S N 2 reactions with Tris.HCl buffer, 13 Tris.H 2 SO 4 buffer 50 mM pH 7.5 (570 µL, 1 mM NADH) was used.
Enzymatic reduction using E. coli/ADH-A in the absence of the nicotinamide cofactor. In a 1.5 mL Eppendorf vial, E. coli/ADH-A (20 mg) was added in Tris-HCl buffer 50 mM pH 7.5 (540 µL) and mixed with 2-propanol (60 μL, 10% v v -1 ) and the corresponding ketone (100 or 200 mM). The reactions were shaken at 30ºC and 250 rpm for 24 h and stopped by extraction with ethyl acetate (2 x 0.5 mL).
The organic layer was separated by centrifugation (2 min, 13000 rpm) and dried over Na 2 SO 4 .
Conversions and ee of the corresponding alcohols were determined by GC.
Enzymatic reduction of ketones at 100 or 200 mM concentration using LBADH. In a 1.5 mL Eppendorf vial, LBADH (3 U) was added in Tris.HCl buffer 50 mM pH 7.5 (540 µL, 1 mM NADP + , 1 mM MgCl 2 ) and mixed with 2-propanol (60 μL, 10% v v -1 ) and the corresponding ketone (100-200 mM). The reactions were shaken at 30ºC and 250 rpm for 24 h and stopped by extraction with ethyl acetate (2 x 1 mL). The organic layer was separated by centrifugation (2 min, 13000 rpm) and dried over Na 2 SO 4 . Conversions and ee of the corresponding alcohols were determined by (chiral) GC (see Table   S1 ). For α-brominated ketones, in order to avoid undesired S N 2 reactions with Tris.HCl buffer, 13 Tris.H 2 SO 4 buffer 50 mM pH 7.5 (540 µL, 1 mM NADP + , 1 mM MgBr 2 ) was used.
Enzymatic reduction of ketones at 100 or 200 mM concentration using E. coli/ADH-A. In a 1.5 mL Eppendorf vial, E. coli/ADH-A (20 mg) was added in Tris.HCl buffer 50 mM pH 7.5 (540 µL, 1 mM NADH) and mixed with 2-propanol (60 μL, 10% v v -1 ) and the corresponding ketone (100-200 mM). The reactions were shaken at 30ºC and 250 rpm for 24 h and stopped by extraction with ethyl acetate (2 x 1 mL). The organic layer was separated by centrifugation (2 min, 13000 rpm) and dried over Na 2 SO 4 . Conversions and ee of the corresponding alcohols were determined by (chiral) GC (see Table   S1 ). For α-brominated ketones, in order to avoid undesired S N 2 reactions with Tris.HCl buffer, 13 Tris.H 2 SO 4 buffer 50 mM pH 7.5 (540 µL, 1 mM NADH) was used.
Enzymatic reduction of ketones at 0.5 M concentration using LBADH. In a 1.5 mL Eppendorf vial, LBADH (3 U) was added in Tris.HCl buffer 50 mM pH 7.5 (480 µL, 1 mM NADP + , 1 mM MgCl 2 )
and mixed with 2-propanol (120 μL, 20% v v -1 ) and the corresponding ketone (0.5 M). The reaction was shaken at 30ºC and 250 rpm for 24 h and stopped by extraction with ethyl acetate (2 x 0.5 mL). The organic layer was separated by centrifugation (2 min, 13000 rpm) and dried over Na 2 SO 4 . Conversions and ee of the corresponding alcohols were determined by GC (see Figure 1 and Table S1 ). For α-brominated ketones, in order to avoid undesired S N 2 reactions with Tris.HCl buffer, 13 Tris.H 2 SO 4 buffer 50 mM pH 7.5 (480 µL, 1 mM NADP + , 1 mM MgBr 2 ) was used.
Scale-up of the bioreductions using LBADH. In a 10 mL glass vial, LBADH (15 U) was added in
Tris.HCl buffer 50 mM pH 7.5 (1 mM NADP + , 1 mM MgCl 2 ) and mixed with 2-propanol (10% v v -1 ) and the corresponding ketone (50 mg, 100 mM). The reaction was shaken at 30ºC and 250 rpm for 24 h and stopped by extraction with diethyl ether (2 x 5 mL). The organic layer was dried over Na 2 SO 4 and the solvent was carefully evaporated (CAUTION: fluorohydrins are highly volatile). Conversions and ee of the corresponding alcohols were determined by GC and NMR. For 2i, in order to avoid undesired S N 2 reactions with Tris.HCl buffer, 13 Tris.H 2 SO 4 buffer 50 mM pH 7.5 (1 mM NADP + , 1 mM MgBr 2 ) was used. In most cases, the final enantiopure products exhibited excellent purity after solvent evaporation, so no further purification was necessary. To obtain (S)-6i, (S)-7f and (S)-7j, flash chromatography was employed to purify the alcohol derivatives. (S)-6i (37 mg, 73% yield, >99% ee), (S)-7a (47 mg, 93%
yield, >99% ee), (S)-7b (44 mg, 87% yield, >99% ee), (S)-7c (36 mg, 71% yield, >99% ee), (S)-7d (46 mg, 91% yield, >99% ee), (S)-7e (44 mg, 87% yield, >99% ee), (S)-7f (33 mg, 64% yield, >99% ee),
